BamSEC and AlphaSense Join Forces
Learn More

Qualigen Therapeutics Inc.

NASDAQ: QLGN    
Share price (10/2/25): $5.59    
Market cap (10/2/25): $9.478 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 19 pages Placement Agent Common Stock Purchase Warrant Qualigen Therapeutics Inc
12/34/56
EX-4.1
from 8-K 16 pages Qualigen Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-4.16
from S-1 36 pages Securities Purchase Agreement
12/34/56
EX-4.15
from S-1 15 pages Form of Pre-Funded Warrant to Purchase Common Stock Qualigen Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 19 pages Qualigen Therapeutics, Inc. Placement Agent Warrant
12/34/56
EX-4.1
from 8-K 15 pages Pre-Funded Warrant to Purchase Common Stock Qualigen Therapeutics, Inc
12/34/56
EX-4.17
from S-1/A 19 pages Qualigen Therapeutics, Inc. Placement Agent Warrant
12/34/56
EX-4.16
from S-1/A 36 pages Securities Purchase Agreement
12/34/56
EX-4.15
from S-1/A 15 pages Form of Pre-Funded Warrant to Purchase Common Stock Qualigen Therapeutics, Inc
12/34/56
EX-4.17
from S-1/A 19 pages Qualigen Therapeutics, Inc. Placement Agent Warrant
12/34/56
EX-4.16
from S-1/A 36 pages Securities Purchase Agreement
12/34/56
EX-4.15
from S-1/A 15 pages Form of Pre-Funded Warrant to Purchase Common Stock Qualigen Therapeutics, Inc
12/34/56
EX-4.17
from S-1/A 19 pages Qualigen Therapeutics, Inc. Placement Agent Warrant
12/34/56
EX-4.16
from S-1/A 36 pages Securities Purchase Agreement
12/34/56
EX-4.15
from S-1/A 15 pages Form of Pre-Funded Warrant to Purchase Common Stock Qualigen Therapeutics, Inc
12/34/56
EX-4.9
from 10-K/A 2 pages Qualigen Therapeutics, Inc. Description of Common Stock
12/34/56
EX-4.1
from 8-K 14 pages Common Stock Purchase Warrant Qualigen Therapeutics, Inc
12/34/56
EX-4.29
from S-3 44 pages Qualigen Therapeutics, Inc. Indenture Dated as of , 20 [ ] Trustee Subordinated Securities
12/34/56
EX-4.28
from S-3 44 pages Qualigen Therapeutics, Inc. Indenture Dated as of , 20 [ ] Trustee Senior Debt Securities
12/34/56
EX-4.16
from 10-Q 12 pages Amended and Restated Common Stock Purchase Warrant Qualigen Therapeutics, Inc. Warrant Shares: 300,000 Initial Exercisability Date: January 26, 2022
12/34/56